EP0956032A4 - Proteines et compositions permettant de moduler la mitose - Google Patents

Proteines et compositions permettant de moduler la mitose

Info

Publication number
EP0956032A4
EP0956032A4 EP97950984A EP97950984A EP0956032A4 EP 0956032 A4 EP0956032 A4 EP 0956032A4 EP 97950984 A EP97950984 A EP 97950984A EP 97950984 A EP97950984 A EP 97950984A EP 0956032 A4 EP0956032 A4 EP 0956032A4
Authority
EP
European Patent Office
Prior art keywords
proteins
compositions
mitosis
modulating
modulating mitosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97950984A
Other languages
German (de)
English (en)
Other versions
EP0956032A1 (fr
Inventor
Wen-Hwa Lee
Yumay Chen
Daniel J Riley
Phang-Lang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of EP0956032A1 publication Critical patent/EP0956032A1/fr
Publication of EP0956032A4 publication Critical patent/EP0956032A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97950984A 1996-12-20 1997-12-17 Proteines et compositions permettant de moduler la mitose Withdrawn EP0956032A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3360096P 1996-12-20 1996-12-20
US33600P 1996-12-20
PCT/US1997/023385 WO1998027994A1 (fr) 1996-12-20 1997-12-17 Proteines et compositions permettant de moduler la mitose

Publications (2)

Publication Number Publication Date
EP0956032A1 EP0956032A1 (fr) 1999-11-17
EP0956032A4 true EP0956032A4 (fr) 2002-09-04

Family

ID=21871338

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950984A Withdrawn EP0956032A4 (fr) 1996-12-20 1997-12-17 Proteines et compositions permettant de moduler la mitose

Country Status (5)

Country Link
EP (1) EP0956032A4 (fr)
JP (1) JP2001507226A (fr)
AU (1) AU5384898A (fr)
CA (1) CA2274734A1 (fr)
WO (1) WO1998027994A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (de) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin-Regulatorgene
US6476193B1 (en) * 1998-10-06 2002-11-05 Curagen Corporation NLK1 protein and NLK1 protein complexes
WO2000029846A2 (fr) 1998-11-13 2000-05-25 Curagen Corporation COMPOSITIONS ET PROCEDES SE RAPPORTANT AUX MECANISMES D'ACTION DU RECEPTEUR-α ACTIVE PAR L'AGENT DE PROLIFERATION DU PEROXYSOME
EP1029547A1 (fr) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Composés pharmaceutiques actifs et procedé pour les identifiér
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (fr) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION
EP1022286A1 (fr) * 1997-10-07 2000-07-26 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, ADNc LE CODANT ET LEUR UTILISATION

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
COMPTON D A ET AL: "PRIMARY STRUCTURE OF NUMA, AN INTRANUCLEAR PROTEIN THAT DEFINES A NOVEL PATHWAY FOR SEGREGATION OF PROTEINS AT MITOSIS", JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 116, no. 6, 1 March 1992 (1992-03-01), pages 1395 - 1408, XP000601680, ISSN: 0021-9525 *
DATABASE GENBANK [online] 20 March 1995 (1995-03-20), HILLIER ET AL.: "The WashU-Merck EST project", XP002203305, Database accession no. T89463 *
DATABASE GENBANK [online] 25 August 1995 (1995-08-25), HILLIER ET AL.: "The WashU-Merck EST project", XP002203306, Database accession no. R92253 *
DURFEE T ET AL: "THE RETINOBLASTOMA PROTEIN ASSOCIATES WITH THE PROTEIN PHOSPHATASE TYPE 1 CATALYTIC SUBUNIT", GENES AND DEVELOPMENT, COLD SPRING HARBOR, NY, US, vol. 7, no. 4, 1 April 1993 (1993-04-01), pages 555 - 567, XP000571493, ISSN: 0890-9369 *
See also references of WO9827994A1 *

Also Published As

Publication number Publication date
CA2274734A1 (fr) 1998-07-02
WO1998027994A1 (fr) 1998-07-02
JP2001507226A (ja) 2001-06-05
EP0956032A1 (fr) 1999-11-17
AU5384898A (en) 1998-07-17

Similar Documents

Publication Publication Date Title
EP0918787A4 (fr) Compositions et procedes pour l'inhibition antisens de la traduction de proteines
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
DE69707905D1 (de) Zusammensetzung zur remineralisierung
EP0963202A4 (fr) Formulations et methodes pour assurer une anesthesie locale prolongee
EP1040117A4 (fr) 110 proteines secretees humaines
EP0960191A4 (fr) Compositions et procedes permettant l'utilisation de defensine
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
DE69726576D1 (de) Probe zur Ortsmarkierung
DK1167392T3 (da) Materialer til anvendelse i papirfremstilling
DE69809660D1 (de) On-line-Rheometervorrichtung
DE69724351D1 (de) System zur Messung von Gewebe-Chromophoren
EP1064022A4 (fr) Peptides de liaison de hla et leurs applications
DE69721231D1 (de) Anisotrop leitende zusammensetzung
EP1109821A4 (fr) 49 proteines humaines secretees
EP1100496A4 (fr) Petites molecules inhibitrices de proteines bcl-2
EP1051426A4 (fr) 67 proteines humaines secretees
EP1064297A4 (fr) 95 proteines humaines secretees
DE69819008D1 (de) Mikroskop zur nachgiebigkeitsmessung
DE59707541D1 (de) Messeinrichtung zur Vermessung von Werkstücken
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
EP0904539A4 (fr) Inhibition d'interactions entre proteines
FI963334A7 (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
EP0956032A4 (fr) Proteines et compositions permettant de moduler la mitose
DE69729604D1 (de) Zusammensetzung zur Geruchsverstärkung
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990716

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020718

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020701